Emami Paper Mills Ltd

Emami Paper Mills Limited: Trading Window closed from Thursday, 1st October, 2026 till the end of 48 hours after the declaration of the Un-audited Financial Results for the Quarter and Half Year ending on 30th September, 2026.

OCRPS redemption

• Redemption completed on 16 September 2026 of 1,125,000 unlisted Series III OCRPS Rs100 face value with Rs600 premium.
• Total redemption amount Rs 78.75 crore funded from profits/reserves/retained earnings.
• OCRPS outstanding reduced to zero post redemption.

AGM Details

• Date and time: 04-Sep-2026 at 11:30 IST.
• Mode: Video Conferencing / Other Audio Visual Means.
• Cut-off for voting: 28-Aug-2026.
• Attendance via VC: 78 total (Promoter 21, Public 57).
• Remote e-voting window: 01-Sep-2026 to 03-Sep-2026.

Key Resolutions

• Ordinary: Adoption of Audited Financial Statements and reports.
• Ordinary: Dividend declaration on equity and preference shares.
• Ordinary: Re-appointment of Manish Goenka as Director.
• Ordinary: Re-appointment of Aditya V. Agarwal as Director by rotation.
• Ordinary: Ratification of Cost Auditor remuneration for FY ended 31 March 2026.
• Ordinary: Revision in remuneration terms of Executive Chairman for period Apr–Jun 2026.
• Special: Re-appointment of Manish Goenka as Whole-time Director and Vice Chairman for 3 years.
• Special: Revision in remuneration terms for Executive Chairman's residual tenure.

Voting Results

• Item 1: Adopted by majority.
• Item 2: Dividend declaration approved.
• Item 3: Goenka re-appointed; majority in favour.
• Item 4: Agarwal re-appointed; majority in favour.
• Item 5: Cost Auditor remuneration ratified.
• Item 6: Exec Chairman remuneration revised; majority.
• Item 7: Goenka as Whole-time Director/Vice Chairman approved.
• Item 8: Exec Chairman remuneration terms revised; approved.

Dividend

• Dividend on equity and preference shares approved; amount not disclosed.

Director Changes

• Manish Goenka re-appointed as Whole-time Director and Vice Chairman.
• Aditya V Agarwal re-appointed as Director by rotation.

Auditors

• Statutory auditor remains unchanged; financial statements adopted.
• Cost Auditor remuneration ratified for the year.

Related Party Transactions

• No material related party transactions approved.

Other Material Approvals

• Remuneration revisions for Executive Chairman and related terms approved.

AGM Details

• 44th AGM on 4 September 2026 at 11:30 IST via VC/OAVM.
• Record date for final dividend set as 28 August 2026.
• Cut-off date for e-voting: 28 August 2026.
• Remote e-voting window: 1 September 2026 09:00 IST to 3 September 2026 17:00 IST.

Dividend

• Record date for final dividend is 28 August 2026.

Materials & Access

• Notice and Annual Report for FY 2025-26 accessible on the company's website.
• Physical copies available on request to the Registrar/Investor Relations.

Financial performance

• Total income ₹1,928.32 crore; revenue from operations ₹1,907.23 crore.
• EBITDA ₹217.18 crore; PBT ₹93.36 crore; PAT ₹61.38 crore.
• EPS: Basic ₹9.34; Diluted ₹8.69 per share.
• EBITDA margin 11.39%; operating margin 8.68%.
• EBITDA grew 48.48% YoY; profitability and earnings quality improved.
• Dividend proposed: 8% preference and 160% equity (₹3.20 per equity share).
• Capex in FY2025-26 ₹30.29 crore funded mainly by internal accruals.

Operations & manufacturing

• Production 3.03 lakh tonnes; installed capacity 3.40 lakh; 100% capacity utilisation.
• PM-2 upgraded with headbox and calendaring; improved sheet formation and finish.
• 7 MW solar power plant commissioned under Group Captive; renewable energy contribution.
• Project Unnati launched to boost procurement efficiency and manufacturing productivity.
• Energy use: total 3,955.51 TJ; renewables 77.31 TJ; non-renewables 3,878.20 TJ.
• New products include Deep-freeze board, GlamKot Premium, OGR Brown Paper and Pharma Inserts.

Product portfolio & R&D

• Portfolio: Newsprint, Writing & Printing, Packaging Board, Specialty Papers, Pharma Inserts, OGR.
• New product launches: Deep-freeze board, GlamKot Premium, OGR Brown Paper, High-Strength Paper, Pharma Insert Paper.
• R&D focus: recyclable, lower GSM papers; fibre optimisation; process efficiency; customer-centric innovation.
• Imported PM-2 headbox and calendaring machinery enhanced product performance.

Capital structure & dividends

• Equity share capital ₹12.10 crore; 6,04,99,050 shares of ₹2 each.
• Convertible preference shares ₹79.57 crore; NCRPS and OCRPS outstanding.
• OCRPS conversion: 15,00,000 OCRPS reclassified to NCRPS; redemption of OCRPS in 2026.
• Debt: non-current ₹403.24 cr; current ₹413.91 cr; total borrowings ₹817.15 cr.
• Net debt ₹895.72 cr; gearing 64%; debt-equity ratio 1.42x.
• Credit rating IND A-/Stable.

Dividends, unclaimed amounts & shareholding

• Unclaimed dividends transferred to IEPF; 1,56,493 equity shares held by IEPF.
• Unclaimed dividends amount ₹11.98 lakh transferred to IEPF (as of 31-03-2026).
• Record date for equity dividend: 28 August 2026; dividend payment within 30 days after AGM.

Governance & risk management

• Board: 10 directors; 5 Independent; CEO Sushil Kumar Khetan appointed Dec 2025.
• CFO Mukesh Kumar Agarwal appointed May 2025; Company Secretary Sumit Jaiswal appointed Mar 2026.
• 8 Board meetings; multiple committees including Audit, NRC, SRC, CSR, and Risk Committee.
• Statutory auditors: S K Agrawal & Co; Secretarial: MKB & Associates; Cost: VK Jain & Co.
• ISO 9001/14001/45001; ERP SAP; robust internal controls and audits.

CSR & ESG highlights

• CSR expenditure ₹174.26 lakh; CSR obligation ₹161.71 lakh; excess ₹12.55 lakh carried forward.
• 7 CSR pillars: Education, Healthcare, Women Empowerment, Rural Development, Environment, Arts & Culture, Livelihoods.
• Notable impact: education for tribal students, health camps, rural development, sapling distribution.
• ISOs & certifications: ISO 9001/14001/45001; Great Place to Work; FSC-COC; USFDA/ BIS certifications.

Outlook & risks

• Indian economy expected to grow ~7% in FY2026-27; packaging demand rising.
• Key risks: raw material cost volatility, currency fluctuations, energy costs, competitive imports, cyber security.
• Opportunities: value-added packaging, OGR and Pharma inserts; export expansion.

Stakeholder engagement & disclosure

• Stakeholder engagement framework covers employees, shareholders, vendors, customers, communities, regulators.
• CSR programs targeted at education, health, livelihood, women empowerment, rural development and environment.
• Grievance redressal processes in place; regular reporting to the Board.

AGM Details

• AGM: 4 September 2026 at 11:30 a.m. IST via VC/OAVM.
• Record date for dividend: 28 August 2026.
• Register of Members closure: 29 Aug to 4 Sep 2026.

Dividend Proposal

• Dividend on Preference Shares: 8% per annum (Rs 8 per share).
• Equity dividend: 160% (Rs 3.20 per equity share of Rs 2).
• Dividend payable to members on record date, subject to AGM.

Ordinary Resolutions

• Res 3: Re-appoint Manish Goenka as Director.
• Res 4: Re-appoint Aditya V. Agarwal as Director.
• Res 5: Ratify Cost Auditor remuneration for 2026-27.

Special Resolutions (Remuneration & Appointments)

• Res 6: Revision in Goenka's remuneration as Vice Chairman from 1 Apr 2026 to 30 Jun 2026.
• Res 7: Re-appoint Goenka as Whole-time Director (Vice Chairman) 1 Jul 2026–30 Jun 2029.
• Res 8: Revision in remuneration of Aditya Agarwal as Executive Chairman from 1 Apr 2026.

Auditor Appointments

• Statutory Auditor: SK Agrawal & Co appointed for 5 years to 2027; remuneration to be fixed by Board.
• Cost Auditor remuneration: Rs 1,65,000 for 2026-27 to M/s V.K. Jain & Co.

OCRPS redemption

• Redeemed 7,50,000 Series II Tranche IV OCRPS at Rs 100 face value plus Rs 500 redemption premium.
• Total redemption amount Rs 45 crore funded from profits reserves retained earnings.
• Redemption date: 31 July 2026.
• OCRPS ISIN is INE830C04053.

Board meeting timing correction

• Corrigendum issued to correct board meeting start time to 12:00 noon.
• Board meeting commenced at 12:00 noon and concluded at 12:40 p.m.
• XBRL filing had 12:00 noon; correction aligns with submission.